Browse the evidence

Bariatric surgery improves cardiovascular risk profiles by significantly altering adipokine secretion profiles, specifically decreasing leptin and increasing adiponectin, independent of simple caloric restriction.

Bariatric surgery is effective not just because it reduces stomach size, but because it fundamentally changes the hormones your fat cells release. It lowers leptin (reducing resistance) and raises adiponectin (improving insulin sensitivity and reducing inflammation), which collectively improve cardiovascular risk.

Higher genetic liability for GrimAge acceleration (a DNA methylation-based biomarker of biological aging) is causally associated with greater adiposity, current tobacco smoking, and lower educational attainment, while being inversely associated with parental longevity.

Your biological age, measured by DNA methylation patterns (GrimAge), is strongly linked to your weight, smoking status, and education level. Maintaining a healthy weight and avoiding smoking can significantly slow down this specific marker of biological aging, potentially extending healthspan and longevity.

Genetic variants associated with Intrinsic Epigenetic Age Acceleration (IEAA) are enriched in pathways related to lipid metabolism, immune function, and hematopoietic stem cell properties, independent of DNA methylation levels at the clock's constituent CpG sites.

Research shows that your genetic makeup influences how your body ages through immune and lipid pathways. While you cannot change your genes, understanding these links highlights the importance of managing inflammation and lipid levels for healthy aging.

Intermittent hypoxia (IH) characteristic of obstructive sleep apnea causes hypertension by dysregulating Hypoxia-Inducible Factors (HIF-1α and HIF-2α), which increases reactive oxygen species (ROS) to activate the sympathetic nervous system and impair baroreflex function.

If you have sleep apnea, the repeated drops in oxygen during sleep trigger a chemical response (HIF/ROS) that keeps your nervous system in 'fight or flight' mode, raising blood pressure even when you are awake. Treating the apnea (e.g., with CPAP) is critical, but because this chemical signaling can persist or cause vascular remodeling, blood pressure may not return to normal without additional targeted interventions. Managing OSA is not just about breathing; it is about stopping the chemical signal that drives hypertension.

Intermittent hypoxia causes insulin resistance and Type 2 Diabetes by increasing ROS in pancreatic beta cells via HIF-1α, leading to hypersecretion of insulin and eventual beta-cell dysfunction.

Sleep apnea doesn't just affect your heart; it stresses your pancreas. The repeated oxygen drops trigger a response (HIF-1/ROS) that forces your beta cells to overwork and secrete too much insulin, leading to insulin resistance and Type 2 Diabetes. Treating your sleep apnea is essential to protect your metabolic health, not just your blood pressure.

Intermittent hypoxia causes cognitive decline and memory impairment by increasing ROS in the hippocampus via HIF-1α, which downregulates NMDA receptors and disrupts synaptic plasticity.

Sleep apnea can physically change your brain's memory centers. The oxygen drops trigger a chemical response (HIF-1/ROS) that damages the connections (NMDA receptors) needed for learning and memory. This isn't just 'brain fog' from being tired; it's structural damage to the hippocampus. Treating OSA may help prevent further cognitive decline.

Acute administration of leptin directly suppresses insulin secretion from pancreatic beta cells and lowers plasma insulin levels in vivo, leading to a rapid rise in blood glucose.

Leptin directly tells your pancreas to stop releasing insulin. In states of high leptin (like obesity), this acute suppression can worsen blood sugar control immediately after eating, even before long-term weight loss effects kick in. This is a direct hormonal signal, not just a brain signal.

Short-term high-dose supplementation with Fructooligosaccharides (FOS) or Galactooligosaccharides (GOS) in healthy young adults causes adverse glycemic metabolism by reducing butyrate-producing bacteria.

If you are healthy, taking high doses of FOS or GOS (16g/day) for short periods might actually worsen your blood sugar response. This contradicts the common belief that prebiotics always help glucose control. The effect is linked to a drop in butyrate-producing bacteria.

FOS and GOS supplementation increases Bifidobacterium abundance but decreases butyrate-producing bacteria (Phascolarctobacterium, Ruminococcus), which correlates with impaired glucose tolerance.

Prebiotics don't just feed 'good' bacteria; they can also suppress other beneficial bacteria that produce butyrate, which is crucial for glucose control. This suggests prebiotics are not universally beneficial for metabolic health.

Glucose is the primary fuel source for immune cells, with activation leading to a rapid increase in glucose consumption and glycolysis, similar to insulin-responsive adipose tissue.

Immune activation requires significant energy, primarily from glucose. While this paper doesn't prescribe a specific glucose intake, it highlights that immune cells metabolize glucose rapidly during activation, linking metabolic health (glucose handling) to immune function.

Maternal overweight/obesity increases the risk of childhood overweight/obesity, with the magnitude of risk being significantly higher for cesarean-delivered infants compared to vaginally delivered infants, mediated sequentially by birth mode and infant gut microbiota (specifically Firmicutes richness and Lachnospiraceae abundance).

For mothers with overweight or obesity, be aware that both vaginal and cesarean delivery carry an increased risk of childhood overweight compared to normal-weight mothers, with cesarean delivery showing a higher risk. This risk is partly mediated by the infant's gut microbiota, specifically the abundance of Lachnospiraceae. While birth mode cannot be changed post-delivery, understanding this link highlights the importance of early gut health. Postnatal factors such as breastfeeding, diet, and antibiotic exposure also shape the microbiome and may offer opportunities to mitigate risk.

Replacing saturated fat with polyunsaturated fat to lower serum cholesterol does not reduce the incidence of cardiovascular events, sudden death, or all-cause mortality in institutionalized populations.

This large, long-term study of institutionalized patients found that while a diet high in polyunsaturated fats successfully lowered blood cholesterol levels, it did not reduce the risk of heart attacks, sudden death, or overall mortality compared to a standard diet. This suggests that simply lowering cholesterol through fat substitution may not be sufficient to prevent cardiovascular death in all populations, particularly those with lower baseline cholesterol or shorter life expectancies.

Excessive extracellular matrix (ECM) remodeling and collagen accumulation in adipose tissue causes fibrosis, which restricts adipocyte expansion, triggers hypoxia and inflammation, and directly leads to insulin resistance.

For those with obesity and insulin resistance, simply losing weight may not be enough if adipose tissue fibrosis is present. Strategies that promote healthy adipose tissue expansion (like moderate, sustained weight loss rather than rapid fluctuations) and reduce inflammation may help preserve tissue elasticity. Resistance training is mentioned as potentially modulating ECM components (MMP-2, VEGF-A, TIMP-2), suggesting it may support healthier adipose tissue structure.

Higher fasting serum TMAO levels are independently associated with increased carotid intima-media thickness (cIMT), an early marker of atherosclerosis, even after adjusting for visceral fat mass, liver fat, and insulin resistance.

High TMAO levels are linked to early artery thickening, independent of your weight or insulin resistance. While you should monitor your intake of choline and carnitine, your metabolic health (how well your body handles insulin) also drives TMAO production. Focus on overall metabolic health, not just avoiding specific foods.

A standard lifestyle intervention (diet and exercise) does not significantly reduce mean serum TMAO levels, even though it improves other cardiovascular risk factors like cIMT, insulin sensitivity, and liver fat.

Even if your TMAO levels don't drop after 9 months of healthy eating and exercise, keep going. You are still improving your insulin sensitivity, liver fat, and artery health. TMAO might be resistant to standard lifestyle changes, but the overall benefit is real.

Industrial trans fatty acids stimulate cholesterol synthesis in the liver by activating SREBP2-mediated gene regulation, leading to increased hepatic cholesterol concentrations and steatosis.

Consuming industrial trans fats may cause your liver to overproduce cholesterol by activating specific genes (SREBP2), contributing to fatty liver and high blood cholesterol levels.

In South Asians, the association between high BMI and cardiovascular disease mortality is weak and less pronounced than in East Asians, with increased risk only observed at very high BMI levels (>35).

For South Asians, the link between BMI and CVD risk is weaker than in East Asians, with significant risk increases primarily seen at very high BMIs (>35). However, because South Asians may carry more abdominal fat at lower BMIs, relying solely on BMI may be misleading. Focus on body composition and waist circumference rather than just weight, and maintain a healthy lifestyle to mitigate risks even at moderate BMIs.

The antioxidant capacity and stability of Cyanidin-3-O-glucoside (Cy3G) are highly dependent on pH, with its oxidative potential shifting approximately 58 mV per pH unit, and it scavenges superoxide radicals effectively but not hydroxyl radicals.

The antioxidant power of Cy3G changes with acidity. It works best against superoxide radicals. Processing methods that alter pH can change its stability and color, which may reflect its chemical state.

Obesity-associated inflammation is driven by tissue-resident and recruited immune cells (specifically Th1, Th17, CD8+, and gamma-delta T cells) in adipose tissue, liver, and gut, creating a feed-forward loop of metabolic decline and comorbidities.

Obesity is not just about calories; it triggers a chronic inflammatory state in fat, liver, and gut tissues. This inflammation is driven by specific immune cells (like T cells) that release inflammatory signals, worsening insulin resistance and metabolic health. Managing obesity requires addressing this inflammatory component, not just weight loss.

Young women with polycystic ovary syndrome (PCOS) exhibit significantly higher levels of high-sensitivity C-reactive protein (hsCRP) and endothelial dysfunction (reduced flow-mediated dilation) compared to healthy, age- and BMI-matched controls, independent of obesity.

If you have PCOS, your risk for early cardiovascular issues is elevated due to inflammation and blood vessel stiffness, even if you are not overweight. This risk is driven by the syndrome's hormonal and metabolic profile, not just body fat. Management should focus on addressing insulin resistance and inflammation, not just weight.

In women with PCOS, endothelial dysfunction (measured by flow-mediated dilation) is significantly correlated with insulin resistance and elevated hsCRP levels, suggesting a mechanistic link between metabolic dysregulation and vascular health.

For women with PCOS, improving insulin sensitivity and reducing inflammation may directly improve blood vessel function. This suggests that treatments targeting insulin resistance (like lifestyle changes or specific medications) could have cardiovascular benefits.

High dietary intake of linoleic acid (an n-6 fatty acid) promotes adipose tissue development and obesity in early life by being converted to arachidonic acid, which activates prostacyclin signaling to stimulate preadipocyte differentiation, whereas n-3 fatty acids inhibit this pathway.

The type of fat you eat matters for your body composition, especially during early development. Diets high in n-6 fatty acids (like corn/soy oils) may promote fat storage through specific hormonal pathways, while n-3 fatty acids (fish/flax oils) may inhibit this process. For adults, this suggests prioritizing n-3 sources and balancing n-6 intake, though the strongest evidence is for developmental stages.

Continuous hyperinsulinemia (loss of pulsatile secretion) directly causes insulin resistance by downregulating insulin receptors and impairing downstream signaling.

Avoid constant snacking or continuous nutrient intake to preserve pulsatile insulin secretion. Pulsatile secretion is essential for maintaining insulin sensitivity and preventing receptor downregulation.

Inhibition of de novo ceramide biosynthesis using myriocin reduces body weight and fat mass in obese mice by increasing energy expenditure and metabolic rate, independent of food intake.

In obese mice, blocking ceramide production with myriocin reduced fat and weight by boosting metabolism, not by reducing food intake.